Endometrial Cancer Clinical Trial
Official title:
Intraoperative Examination of Sentinel Node for The Decision of Further Lymphadenectomy in Clinical Early Stage Endometrial Cancer: A Diagnostic Study of Turkish Gynecologic Oncology Group (TRSGO-SLN-003)
More than half of the cases with macrometastatic sentinel lymph node (SLN) have non-SLN metastasis and leaving these nodes in-situ may impair the survival. This study assessed the diagnostic accuracy of intraoperative SLN frozen section examination and scrape cytology as a possible solution for management of SLN positive patients. Clinical early stage endometrial cancer patients who underwent SLN algorithm and intraoperative frozen section or scrape cytology to evaluate SLN status for metastasis were analyzed retrospectively. Intraoperative examination findings were compared with final pathology results and diagnostic accuracy of frozen section and scrape cytology were evaluated.
Frozen section: Lymph nodes up to 2 mm were embedded as a whole. Lymph nodes between 2-5 mm
were cut in half along their long axis and nodes larger than 5 mm were sliced in neat,
parallel slices at 2-3 mm intervals-slicing was perpendicular to the long axis of the node.
Then whole of the SLNs were stained with hematoxylin and eosin (H&E) and examined by frozen
section.
Scrape Cytology: SLNs were cut into 3-mm-thick pieces along their long axis. If the lymph
node was smaller than 3 mm, it was cut in half. Both sides of the pieces were scraped
separately by an edge of a glass slide or a lancet gently. Obtained materials were smeared
immediately onto a slide and placed in ethanol for fixation. Then, all slides were stained
with H&E and examined.
The results were reported to the surgeon as positive (metastatic) or negative with the
numbers of lymph nodes. After intraoperative examination, lymph nodes were put into formalin
solution and sent for final pathologic examination.
Data analyses were performed using SPSS Version 21.0 (IBM Corporation, Armonk, NYC, USA).
Shapiro-Wilk test was performed to determine whether the data were normally distributed.
Descriptive statistics of continuous variables were compared between groups using
Mann-Whitney U test. The Chi-square test or Fisher's exact test (when chi-square test
assumptions do not hold due to low expected cell counts) were used to compare categorical
variables between groups. Continuous variables were presented as median and min-max values,
whereas categorical variables were presented as number and percentage. A p value of <0.05 was
considered statistically significant. Performance of each protocol to predict treatment
success was assessed using confidence intervals with respect to sensitivity, specificity,
positive predictive value, and negative predictive value.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT05483023 -
18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy
|
Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04586335 -
Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03665285 -
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03820024 -
MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
|
N/A | |
Active, not recruiting |
NCT00587886 -
Estrogen, Diet, Genetics and Endometrial Cancer
|
||
Recruiting |
NCT05124743 -
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
|
||
Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
Recruiting |
NCT04569773 -
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
|
||
Active, not recruiting |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A | |
Terminated |
NCT02907073 -
Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
|
Phase 1/Phase 2 | |
Recruiting |
NCT02413606 -
ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?
|
N/A | |
Completed |
NCT02549989 -
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
|
Phase 2 | |
Completed |
NCT02096783 -
Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer
|
N/A | |
Completed |
NCT01979003 -
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
|
Early Phase 1 | |
Completed |
NCT02058550 -
Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
|
Phase 1 | |
Completed |
NCT01922778 -
Screening for Endometrial Abnormalities in Overweight and Obese Women
|
N/A | |
Completed |
NCT02351479 -
Hula, a Physical Activity Intervention for Female-Cancer Survivors
|
N/A |